Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1571602
PUBLISHER: Grand View Research | PRODUCT CODE: 1571602
U.S. Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment Drug Screens), By Product, By Mode, By Drug, By End-use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
U.S. Employer And Workplace Drug Testing Market Growth & Trends:
The U.S. employer and workplace drug testing market size is anticipated to reach USD 3.47 billion by 2030, growing at a CAGR 5.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Regulatory compliance is a significant driver for market growth. Federal regulations, such as those from the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA), mandate testing for safety-sensitive roles to ensure workplace safety and mitigate liability risks. These regulations enforce testing across industries, especially those involving heavy machinery or transportation.
In 2020, the American Public Health Association further emphasized the importance of drug testing by advocating for comprehensive strategies to address Opioid Use Disorder (OUD) and overdose risks in occupational settings. Their recommendations included strengthening injury prevention programs, addressing ergonomic risks, providing opioid misuse education, offering peer support, and regulating opioid prescriptions through workers' compensation. This policy push underscores the growing need for proactive drug testing measures.
In response to these regulatory and policy pressures, the U.S. DOT finalized new regulations in May 2023, allowing oral fluid testing for DOT-mandated drug tests, provided that at least two SAMHSA-certified laboratories are involved. This development highlights the evolving landscape of drug testing, enhancing the flexibility and accuracy of testing programs. By broadening testing options, the new regulation is expected to drive demand for oral fluid testing solutions, benefiting both employers and testing providers and supporting the overall market growth.
Additionally, the increase in substance use disorders (SUDs) among the workforce significantly impacts the growth of the U.S. employer & workplace drug testing market. The prevalence of these disorders contributes to higher rates of absenteeism, lower productivity, and increased workplace accidents. Employers are therefore compelled to implement rigorous drug testing programs to identify and address substance abuse issues promptly. This proactive approach not only helps in maintaining a safe and productive work environment but also reduces operational risks and legal liabilities associated with impaired employees. The growing recognition of the adverse effects of SUDs drives demand for more advanced and comprehensive drug testing solutions, contributing to the market's expansion.
Furthermore, as organizations prioritize creating safer work environments, drug testing becomes an essential component of their safety programs. The awareness of the risks associated with substance abuse, including impaired judgment and increased accident rates, motivates employers to implement robust policies. This focus on safety is particularly pronounced in high-risk industries such as construction, manufacturing, and transportation. By identifying and addressing substance abuse issues, employers can mitigate potential hazards, improve overall workplace safety, and reduce associated costs. The increased awareness and commitment to safety drive the demand for comprehensive solutions, fueling market growth.
U.S. Employer And Workplace Drug Testing Market Report Highlights:
- Based on type, the post-employment segment dominated the market with a revenue share of 80.80% in 2023. Reducing the risk of accidents, workplace injuries, and associated liabilities is a crucial driver for post-employment drug testing in the U.S. Employers in high-risk industries such as construction, transportation, and manufacturing are acutely aware of the dangers posed by impaired employees to workplace safety.
- Based on product, the consumable segment dominated the market with a revenue share of 33.42% in 2023. This segment is vital for ensuring the accuracy and reliability of drug tests, which directly impacts the effectiveness of drug screening programs. The regulatory landscape significantly influences the consumables segment, with federal guidelines from the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA) setting specific standards for drug testing procedures and associated products.
- Based on mode, the urine segment held the largest market share of 41.38% in 2023. Urine tests are the most common type of pre-employment drug tests used by employers, driven by their established reliability and ease of use. This method remains a staple in both regulated and non-regulated industries, ensuring consistent application across various sectors.
- Based on drug, the cannabis/marijuana segment held the largest market share of 56.89% in 2023 and is expected to grow at the fastest CAGR over the forecast period. The legalization and decriminalization of marijuana in many states has diminished the stigma surrounding its use, leading to increased consumption, including among employees.
- Based on end-use, the other professional services segment dominated the market with the largest revenue share of 39.11% in 2023. The demand for employer and workplace drug testing in the U.S. is driven across various professional services sectors, including Professional, Scientific and Technical, Wholesale Trade, and Public Administration industries, due to the critical nature of their work and the need for maintaining high standards of safety, compliance, and productivity.
- The competitive scenario in the pediatric cardiac tumor diagnostic market is high. The major companies are undertaking various strategies such as new product development, collaborations, acquisitions, and mergers for serving the unmet needs of their customers.
Product Code: GVR-4-68040-450-9
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Type Segment
- 1.2.2. Product Segment
- 1.2.3. Mode Segment
- 1.2.4. Drug Segment
- 1.2.5. End Use Segment
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. U.S. Employer and Workplace Drug Testing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. U.S. Employer and Workplace Drug Testing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Employer and Workplace Drug Testing Market Type Movement Analysis
- 4.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. Pre-employment Drug Screens
- 4.4.1. Pre-employment drug screens market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Post-employment
- 4.5.1. Post-employment market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Employer and Workplace Drug Testing Market Product Movement Analysis
- 5.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 5.4. Consumables
- 5.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Instruments
- 5.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Rapid Testing Devices
- 5.6.1. Rapid testing devices market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Services
- 5.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Employer and Workplace Drug Testing Market Mode Movement Analysis
- 6.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
- 6.4. Urine
- 6.4.1. Urine market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Hair
- 6.5.1. Hair market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Oral Fluid
- 6.6.1. Oral fluid market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Instant testing
- 6.7.1. Instant testing market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. U.S. Employer and Workplace Drug Testing Market Drug Movement Analysis
- 7.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Drug, 2018 to 2030 (USD Million)
- 7.4. Alcohol
- 7.4.1. Alcohol market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Cannabis/Marijuana
- 7.5.1. Cannabis/marijuana market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Cocaine
- 7.6.1. Cocaine market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Opioids
- 7.7.1. Opioids testing market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. Amphetamine & Methamphetamine
- 7.8.1. Amphetamine & methamphetamine market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9. LSD
- 7.9.1. LSD market estimates and forecasts 2018 to 2030 (USD Million)
- 7.10. Others
- 7.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. U.S. Employer and Workplace Drug Testing Market: End Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. U.S. Employer and Workplace Drug Testing Market End Use Movement Analysis
- 8.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 8.4. IT/Finance
- 8.4.1. IT/finance market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5. Manufacturing
- 8.5.1. Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6. Transportation
- 8.6.1. Transportation market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7. Construction
- 8.7.1. Construction market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8. Retail and Hospitality
- 8.8.1. Retail and hospitality market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9. Healthcare
- 8.9.1. Healthcare market estimates and forecasts 2018 to 2030 (USD Million)
- 8.10. Education
- 8.10.1. Education surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
- 8.11. Other Professional Services
- 8.11.1. Other Professional Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company/Competition Categorization
- 9.2. Strategy Mapping
- 9.3. Company Market Position Analysis, 2023
- 9.4. List of Key Certification Providers/Scheme Owners
- 9.5. Company Profiles/Listing
- 9.5.1. First Advantage
- 9.5.1.1. Company overview
- 9.5.1.2. Financial performance
- 9.5.1.3. Product benchmarking
- 9.5.1.4. Strategic initiatives
- 9.5.2. Laboratory Corporation of America Holdings (Labcorp)
- 9.5.2.1. Company overview
- 9.5.2.2. Financial performance
- 9.5.2.3. Product benchmarking
- 9.5.2.4. Strategic initiatives
- 9.5.3. Dragerwerk AG & Co. KGaA
- 9.5.3.1. Company overview
- 9.5.3.2. Financial performance
- 9.5.3.3. Product benchmarking
- 9.5.3.4. Strategic initiatives
- 9.5.4. Bio-Rad Laboratories, Inc.
- 9.5.4.1. Company overview
- 9.5.4.2. Financial performance
- 9.5.4.3. Product benchmarking
- 9.5.4.4. Strategic initiatives
- 9.5.5. Abbott
- 9.5.5.1. Company overview
- 9.5.5.2. Financial performance
- 9.5.5.3. Product benchmarking
- 9.5.5.4. Strategic initiatives
- 9.5.6. Clinical Reference Laboratory Inc.
- 9.5.6.1. Company overview
- 9.5.6.2. Financial performance
- 9.5.6.3. Product benchmarking
- 9.5.6.4. Strategic initiatives
- 9.5.7. Quest Diagnostics
- 9.5.7.1. Company overview
- 9.5.7.2. Financial performance
- 9.5.7.3. Product benchmarking
- 9.5.7.4. Strategic initiatives
- 9.5.8. Cordant Health Solutions
- 9.5.8.1. Company overview
- 9.5.8.2. Financial performance
- 9.5.8.3. Product benchmarking
- 9.5.8.4. Strategic initiatives
- 9.5.9. DISA Global Solutions
- 9.5.9.1. Company overview
- 9.5.9.2. Financial performance
- 9.5.9.3. Product benchmarking
- 9.5.9.4. Strategic initiatives
- 9.5.10. HireRight, LLC
- 9.5.10.1. Company overview
- 9.5.10.2. Financial performance
- 9.5.10.3. Product benchmarking
- 9.5.10.4. Strategic initiatives
- 9.5.11. OraSure Technologies, Inc.
- 9.5.11.1. Company overview
- 9.5.11.2. Financial performance
- 9.5.11.3. Product benchmarking
- 9.5.11.4. Strategic initiatives
- 9.5.12. Psychemedics Corporation
- 9.5.12.1. Company overview
- 9.5.12.2. Financial performance
- 9.5.12.3. Product benchmarking
- 9.5.12.4. Strategic initiatives
- 9.5.13. Omega Laboratories
- 9.5.13.1. Company overview
- 9.5.13.2. Financial performance
- 9.5.13.3. Product benchmarking
- 9.5.13.4. Strategic initiatives
- 9.5.1. First Advantage
Product Code: GVR-4-68040-450-9
List of Tables
- Table 1 List of abbreviation
- Table 2 U.S. employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
- Table 3 U.S. employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
- Table 4 U.S. employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
- Table 5 U.S. employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
- Table 6 U.S. employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 U.S. employer and workplace drug testing market segmentation
- Fig. 2 Data analysis models
- Fig. 3 Market formulation and validation
- Fig. 4 Data validating & publishing
- Fig. 5 Market research process
- Fig. 6 Information procurement
- Fig. 7 Primary research
- Fig. 8 Value-chain-based sizing & forecasting
- Fig. 9 QFD modelling for market share assessment
- Fig. 10 Market formulation & validation
- Fig. 11 Commodity flow analysis
- Fig. 12 Market outlook
- Fig. 13 Segment snapshot-1
- Fig. 14 Segment snapshot-2
- Fig. 15 Competitive landscape snapshot
- Fig. 16 Market trends & outlook
- Fig. 17 Porter's five force analysis
- Fig. 18 PESTEL analysis
- Fig. 19 U.S. employer and workplace drug testing market: Type outlook key takeaways
- Fig. 20 U.S. employer and workplace drug testing market: Type movement analysis
- Fig. 21 Pre-employment drug screens market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 22 Post-employment market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 23 U.S. employer and workplace drug testing market: Product outlook key takeaways
- Fig. 24 U.S. employer and workplace drug testing market: Product movement analysis
- Fig. 25 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 26 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 27 Rapid testing devices market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 28 Services market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 29 U.S. employer and workplace drug testing market: Mode outlook key takeaways
- Fig. 30 U.S. employer and workplace drug testing market: Mode movement analysis
- Fig. 31 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 32 Hair market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 33 Oral fluid market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 34 Instant testing estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 35 U.S. employer and workplace drug testing market: Mode outlook key takeaways
- Fig. 36 U.S. employer and workplace drug testing market: Mode movement analysis
- Fig. 37 Alcohol market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 38 Cannabis/marijuana market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 39 Cocaine market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 40 Opioids estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 42 LSD market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 44 U.S. employer and workplace drug testing market: End use outlook key takeaways
- Fig. 45 U.S. employer and workplace drug testing market: End use movement analysis
- Fig. 46 IT/finance market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 47 Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 48 Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 49 Construction estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 50 Retail and hospitality market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 51 Healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 52 Education market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 53 Other professional services market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 54 Market participant categorization
- Fig. 55 U.S. employer and workplace drug testing market position analysis, 2023
- Fig. 56 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.